Regulating Nanomedicine: A European Perspective
Posted: 28 Feb 2012 Last revised: 22 Feb 2014
Date Written: October 18, 2008
Abstract
The potential impact of nanomedicine is foreseen to radically change health care; however it also challenges existing perceptions, dynamics and standards relating to ethics, safety and governance. This commentary briefly highlights aspects and approaches pertaining to nanomedical regulation in the European Union.
Keywords: Nanotechnology, nanomedicine, regulation, technologies, Law
JEL Classification: K32
Suggested Citation: Suggested Citation
D'Silva, Joel and van Calster, Geert, Regulating Nanomedicine: A European Perspective (October 18, 2008). Available at SSRN: https://ssrn.com/abstract=1286215 or http://dx.doi.org/10.2139/ssrn.1286215
Feedback
Feedback to SSRN
If you need immediate assistance, call 877-SSRNHelp (877 777 6435) in the United States, or +1 212 448 2500 outside of the United States, 8:30AM to 6:00PM U.S. Eastern, Monday - Friday.